CMPI.org

In the News

CMPI President Peter J. Pitts discusses the Opioid Crisis on i24NEWS

06/12/2017 12:00 AM | i24NEWS

Regenerative Medicine Can Help Make America Great

06/12/2017 12:00 AM | Morning Consult

Managed Care Magazine Launches Attack on Orphans

06/09/2017 12:00 AM | LinkedIn

When it comes to faster access to drugs, first do no harm

06/04/2017 12:00 AM | The Hill

The False Promise of Drug-Price Controls

05/19/2017 12:00 AM | National Review

Selective Transparency

05/18/2017 12:00 AM | The Institute for Policy Innovation

ICER Perpetuates the Opioid Crisis

05/11/2017 12:00 AM | Morning Consult

Blue Cross Blue Shield BS on Rx $

05/09/2017 12:00 AM | LinkedIn

Safety Events Common in Newly Approved Drugs

05/09/2017 12:00 AM | Medscape

Peter Pitts discusses Scott Gottlieb and Healthcare Reform on the Bill Martinez Radio Show

05/09/2017 12:00 AM | Bill Martinez Radio Show

Peter Pitts on Healthcare Bill's Passage in US House

05/04/2017 12:00 AM | i24NEWS

Making Drug Manufacturing Great Again

04/21/2017 12:00 AM | Investor's Business Daily

Peter Pitts discusses progress of GOP Healthcare Bill on i24NEWS

04/21/2017 12:00 AM | i24NEWS

Peter Pitts on Fox News: How the pharmaceutical industry fits into the opioid crisis

04/11/2017 12:00 AM | Fox News

Peter Pitts on WOR 710 "In The Arena"

04/11/2017 12:00 AM | WOR 710

How Trump and the FDA Can Create a Pharmaceutical Manufacturing Renaissance

04/10/2017 12:00 AM | Morning Consult

ICER Devalues People With Rheumatoid Arthritis

03/29/2017 12:00 AM | LinkedIn

Peter Pitts on CNBC: Revised 'bottom up' US healthcare bill delayed

03/23/2017 12:00 AM | CNBC

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

03/16/2017 12:00 AM | Medical Marketing & Media

CMPI President Peter J. Pitts discusses the American Health Care Act on i24News

03/14/2017 12:00 AM | i24NEWS

Previous
1
...
7
8
9
10
11
12
Next

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

The Journal of Clinical Investigation
08/17/2026 12:00 AM

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients... Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

CMPI
08/10/2026 12:00 AM

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis... Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

CMPI
02/03/2026 12:00 AM

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo... Read more

Read all News